ChiCTR2300069198 版本V1.1 版本创建时间2023/07/06 09:14:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300069198 

最近更新日期:

Date of Last Refreshed on:

2023-03-09 14:26:06 

注册时间:

Date of Registration:

2023-03-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

重症脑卒中患者营养不良-炎症状态与神经功能预后的关系研究

Public title:

Study on the relationship between malnutrition-inflammatory state and neurological prognosis in patients with severe stroke

注册题目简写:

English Acronym:

研究课题的正式科学名称:

重症脑卒中患者营养不良-炎症状态与神经功能预后的关系研究

Scientific title:

Study on the relationship between malnutrition-inflammatory state and neurological prognosis in patients with severe stroke

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

阳佳家 

研究负责人:

李凤 

Applicant:

Yang Jiajia 

Study leader:

Li Feng 

申请注册联系人电话:

Applicant telephone:

15703050899

研究负责人电话:

Study leader's telephone:

13752905801

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2308293006@qq.com

研究负责人电子邮件:

Study leader's E-mail:

954036024@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市重庆医科大学附属第一医院神经内科

研究负责人通讯地址:

重庆市重庆医科大学附属第一医院神经内科

Applicant address:

Department of Neurology, First Hospital of Chongqing Medical University, Chongqing

Study leader's address:

Department of Neurology, First Hospital of Chongqing Medical University, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属第一医院

Applicant's institution:

The First Hospital of Chongqing Medical University

研究负责人所在单位:

重庆医科大学附属第一医院

Affiliation of the Leader:

The First Hospital of Chongqing Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023年科研伦理(2023-049)

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-01-11 00:00:00

伦理委员会联系人:

严青

Contact Name of the ethic committee:

Yan Qing

伦理委员会联系地址:

重庆市渝中区袁家岗友谊路1号

Contact Address of the ethic committee:

No.1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属第一医院

Primary sponsor:

The First Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区袁家岗友谊路1号重庆医科大学附属第一医院

Primary sponsor's address:

The First Hospital of Chongqing Medical University, No.1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第一医院

具体地址:

重庆市渝中区袁家岗友谊路1号

Institution
hospital:

The First Hospital of Chongqing Medical University

Address:

No.1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing

经费或物资来源:

自拟项目

Source(s) of funding:

Self-proposed projects

Target disease:

stroke

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

巢式病例-对照研究 

Study design:

Nested case-control study 

研究目的:

将生物电阻抗分析(BIA)相关指标作为反映患者营养不良-炎症状态指的指标,拟使用生物电阻抗分析对神经重症监护室(NICU)中脑卒中患者进行客观动态监测,以期动态观察卒中患者急性期营养不良-炎症状态对预后的影响,为临床采取营养支持及抗炎干预措施以改善卒中患者结局提供参考依据。  

Objectives of Study:

Bioelectrical impedance analysis (BIA) was used as an indicator to reflect the malnutrition-inflammatory state of patients, and bioelectrical impedance analysis was proposed to objectively and dynamically monitor stroke patients in the neurointensive care unit (NICU), in order to dynamically observe the influence of acute malnutrition-inflammatory state on the prognosis of stroke patients, and provide a reference for clinical nutrition support and anti-inflammatory interventions to improve the outcomes of stroke patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄≥18岁;
(2)入住NICU的脑卒中患者 ;
(3)所有患者或其监护人均提供了书面知情同意。

Inclusion criteria

(1) Age≥ 18 years old;
(2) stroke patients admitted to the NICU;
(3) All patients or their guardians have provided written informed consent.

排除标准:

(1)因躁动不安、血流动力学不稳定、截肢等无法使用BIA测量、植入了金属装置(如起搏器或人工股骨头) 而无法接受BIA测试或BIA值错误及在BIA电极附着区域遭受皮肤损伤的患者;
(2)资料不齐全

Exclusion criteria:

(1) Patients who cannot receive BIA tests or incorrect BIA values due to restlessness, hemodynamic instability, amputation, etc., who cannot be measured by BIA, implanted metal devices (such as pacemakers or artificial femoral heads), and suffer skin damage in the area where BIA electrodes are attached;
(2) Incomplete information

研究实施时间:

Study execute time:

From 2023-03-01 00:00:00 To 2028-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-04-01 00:00:00 To 2027-03-01 00:00:00  

干预措施:

Interventions:

组别:

病例组

样本量:

76

Group:

Case group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

对照组

样本量:

76

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

重庆医科大学附属第一医院 

单位级别:

三级甲等医院 

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Level of the institution:

Grade A class 3 hospital

测量指标:

Outcomes:

指标中文名:

出院后3个月神经功能预后

指标类型:

主要指标

Outcome:

Neurological prognosis 3 months after discharge

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住NICU时间

指标类型:

次要指标

Outcome:

length of study in NICU

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

无标本

组织:

Sample Name:

No sample

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究不涉及随机方法

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

收集脑卒中患者入NICU24小时内的临床资料、入院24小时的生化资料和入院后连续动态的BIA指标,电话随访患者出院后3个月的神经功能预后。所有资料由2名专门的研究助理通过电子病历系统及BIA(InBody S10)仪器记录系统、电话随访进行收集整理,且分别进行数据录入。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The clinical data of stroke patients within 24 hours of admission to the NICU, the biochemical data of 24 hours of admission and the continuous dynamic BIA indicators after admission were collected, and the neurological prognosis of patients 3 months after discharge was followed up by telephone. All data were collected and collated by two dedicated research assistants through the electronic medical record system, BIA (InBody S10) instrument recording system, telephone follow-up, and data entry was carried out separately.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-03-09 14:25:48